Ongoing excellent outcomes with reduced toxicities following integration of molecular targeted therapies in pediatric anaplastic large cell lymphoma.
作者:
主题词
儿童(Child);人类(Humans);纵向研究(Longitudinal Studies);淋巴瘤, 大细胞, 间变性(Lymphoma, Large-Cell, Anaplastic);分子靶向治疗(Molecular Targeted Therapy)
DOI
10.1080/10428194.2021.1894644
PMID
33685326
发布时间
2021-08-16
- 浏览0

Leukemia & lymphoma
1995-1999页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文